Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabineGiulio Metro, Stefania Gori, Jennifer Foglietta et al.|Annals of Oncology|2010Cited by 168
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study.Marina Elena Cazzaniga, Benedetta Pellegrino, Graziella Pinotti et al.|Journal of Clinical Oncology|2017Cited by 2
Outcome of patients (pts) with brain metastases (BMs) from HER2-positive breast cancer (BC) treated with lapatinib plus capecitabine (LC).Giulio Metro, Stefania Gori, Jennifer Foglietta et al.|Journal of Clinical Oncology|2010Cited by 1
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 StudyMarina Elena Cazzaniga, Valter Torri, Maria Rosaria Valerio et al.|The Breast|2017Cited by 0